Who founded Deep Genomics?

Deep Genomics was founded by Brendan Frey in 2014.

Who are Deep Genomics's investors?

Deep Genomics's investors include 11.2 Capital, Future Ventures, Kensington Capital Partners Limited, Magnetic Ventures, SoftBank Vision Fund, True Ventures, Bloomberg Beta.

Where is Deep Genomics headquartered?

Deep Genomics is headquartered in Toronto, CA.

Deep Genomics

Toronto, CA · Founded 2014 · 112 employees on LinkedIn · 7 known investors

Find your way into Deep Genomics

248 people in our graph share verified history with the Deep Genomics team — schools, employers, funds. One of them is your warm intro.

Nessan Berminghamunlockedknows Brendan Frey · together at Deep Genomics (overlapped)

×6knows the team · via University of Calgary

knows the team · via Microsoft Research

×4knows the team · via University of Manitoba

Deep Genomics develops AI-based biological foundation models to identify drug targets and design molecules, aiming to speed up drug discovery. Its platform combines lab-in-the-loop workflows, training datasets, and screening technologies to find candidates for developing new medicines.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Deep Genomics was founded in 2014 by Brendan Frey.

Brendan Frey inChief Innovation Officer and FounderBrendan Frey founded Deep Genomics in 2015 to develop machine learning approaches for genetic medicine and drug discovery. He is a professor of engineering and medicine at the University of Toronto and has authored over 200 peer-reviewed papers on machine learning and genomics, including contributions to Nature, Science, and Cell.

Brian O'CallaghaninChief Executive Officer

David JohnstoninChief Financial Officer

Clive BertraminChief Business Officer

Tom MastersoninChief Operating Officer

Greg HoffmaninChief Scientific Officer

Investors · 7

11.2 CapitalLas Vegas · $500K – $3M

Future VenturesLos Altos · $1M – $10M

Kensington Capital Partners LimitedToronto

Magnetic VenturesBoston · $1M – $6M

SoftBank Vision FundLondon

True VenturesSan Francisco · $500K – $3Mvia Adam D'Augelli · led

Bloomberg BetareportedSan Francisco · $25K – $1M

Founder mafia

4 people who came through Deep Genomics went on to found or lead other companies.

Nessan BerminghamBoard MemberFounded Korro Bio +2 Paul SekhriMember Board of DirectorsFounded Vtvtherapeutics Philip FradkinComputational BiologistFounded Blank Bio Dorsa RohaniMachine Learning InternFounded Mosaic

Competitors · 4

by search overlap

Oup17 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

Genomics Plc14 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.

10x Genomics 1-color13 shared keywords10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.

IDbyDNA13 shared keywordsScalable, high throughput DNA sequencing platforms.

Companies competing with Deep Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Deep Genomics do?: Deep Genomics develops AI-based biological foundation models to identify drug targets and design molecules, aiming to speed up drug discovery. Its platform combines lab-in-the-loop workflows, training datasets, and screening technologies to find candidates for developing new medicines.
Who founded Deep Genomics?: Deep Genomics was founded by Brendan Frey in 2014.
Who are Deep Genomics's investors?: Deep Genomics's investors include 11.2 Capital, Future Ventures, Kensington Capital Partners Limited, Magnetic Ventures, SoftBank Vision Fund, True Ventures, Bloomberg Beta.
Where is Deep Genomics headquartered?: Deep Genomics is headquartered in Toronto, CA.